Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals Inc (MIRM) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Maralixibat, is Mirum Pharmaceuticals lead product candidate. The product is an investigational oral drug in development for the following conditions:  

• Alagille syndrome (ALGS)
• Progressive familial intrahepatic . . .
  
  This content is for paid subscribers.
  Please click here to subscribe or here to log in.
  Trick or Trade

  Mirum Pharmaceuticals Inc (MIRM), Takeda Pharmaceutical Limited (TAK)

  September 27, 2021
  Tweet Pin It